Adherence to Guidelines for Community-Acquired Pneumonia Patricia D. Brown Leading Article 22 September 2012 Pages: 413 - 420
Economic Evaluations of Treatments for Systemic Fungal Infections Simon DixonEmma McKeenSuzy Paisley Review Article 22 September 2012 Pages: 421 - 433
Management and Costs of Treating Lung Cancer Patients in a University Hospital Konstantin J. DedesThomas D. SzucsRolf A. Stahel Original Research Article 22 September 2012 Pages: 435 - 444
Drotrecogin Alfa (Activated) James E. FramptonRachel H. Foster Adis Pharmacoeconomic Drug Evaluation 22 September 2012 Pages: 445 - 476
Cost Effectiveness of Peginterferon α-2a Plus Ribavirin versus Interferon α-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C Miguel Arguedas Correspondence 22 September 2012 Pages: 477 - 478
Cost Effectiveness of Peginterferon α-2a Plus Ribavirin versus Interferon α-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C. The Authors’ Reply Sean D. SullivanKavita PatelJesse Green Correspondence 22 September 2012 Pages: 478 - 478